Author name: DrugChatter

There’s a particular moment in modern pharmacology that doesn’t show up in clinical trials or prescribing inserts. It happens at […]

When a patient asks ChatGPT whether Ozempic or Mounjaro is better for weight loss, they get an answer. Not a

And while clinicians think in terms of CYP enzymes and receptor binding, patients often think in simpler terms: Can I

Drug safety surveillance has a new blind spot. Millions of patients are now asking ChatGPT, Gemini, Claude, and Perplexity about

Prescribing information is the most legally precise document in medicine. Every word in a package insert has survived FDA review,

When Pfizer launched Paxlovid in late 2021, the company had a distribution problem, a supply chain problem, and a rebound

Pregnancy is one of those states where pharmacology becomes less about mechanism diagrams and more about uncertainty management. The questions

Alcohol has a way of slipping into medical conversations whether clinicians invite it or not. Patients rarely ask about it

A patient in Phoenix types ‘is Ozempic safe for someone with a history of pancreatitis?’ into ChatGPT at 11 p.m.

There’s a persistent habit in medicine—and especially in patient questions online—of treating antibiotics as if they were interchangeable with everyday

In late 2023, a patient with type 2 diabetes asked ChatGPT whether semaglutide could eliminate the need for insulin entirely.

In 2023, a patient asked ChatGPT whether she could take Eliquis with ibuprofen. ChatGPT told her the combination was generally